Fig. 1From: Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in CanadaPercentage reduction in attack rate and treated attacks after initiating lanadelumab. Number of attacks and treated attacks were calculated using the total number from the year preceding and the year following initiation of lanadelumabBack to article page